Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00345930 · ClinicalTrials.gov registry record

DILIN - Prospective Study

A clinical trial of Liver Diseases, sponsored by Duke University.

Recruiting
Registry status
4,000
Enrollment target
6
Study locations

NCT00345930 is a study of Liver Diseases that is actively recruiting participants, run by Duke University. The registered enrollment target is 4,000 participants, below the 61,037-participant average among 33 other Liver Diseases trials with a reported enrollment target (93% lower). The trial reports 6 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00345930, a study of Liver Diseases, is actively recruiting participants, sponsored by Duke University.

RECRUITING
Registry status
4,000 participants
Enrollment target
6
Study locations

Study Summary

The purpose of this study is to identify individuals who have suffered a liver injury arising as an idiosyncratic reaction to a prescription drug or a complementary and alternative medicine. Recently added acute cases enrollment that meets criteria to the protocol. Also added Fibroscans to the protocol that will be completed at baseline and follow-up on chronic subjects.

Conditions Studied

Liver Diseases

Study Locations (6)

California

  • University of Southern California - Los Angeles

Indiana

  • Indiana University - Indianapolis

Maryland

  • NIH Clinical Site - Bethesda

Michigan

  • University of Michigan - Ann Arbor

North Carolina

  • Univeristy of North Carolina at Chapel Hill - Chapel Hill

Pennsylvania

  • Thomas Jefferson - Philadelphia

Trial Details

FieldValue
Enrollment Target 4,000 participants
Start Date 2004-09
Est. Completion 2028-07-31

Sponsor

Duke University

1,725 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00345930

The ClinicalTrials.gov registry entry for NCT00345930 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 4,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 61,037-participant average among 33 other Liver Diseases trials with a reported enrollment target (93% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Liver Diseases appearing as the primary indexed condition, and to 0 interventions.

NCT00345930 reports 6 study locations spanning 6 distinct geographic areas - top geographies include California, Indiana, Maryland.

Frequently Asked Questions

What is clinical trial NCT00345930 about?

NCT00345930 is a clinical study titled "DILIN - Prospective Study". The purpose of this study is to identify individuals who have suffered a liver injury arising as an idiosyncratic reaction to a prescription drug or a complementary and alternative medicine. Recently added acute cases enrollment that meets criteria to the protocol. Also added Fibroscans to the proto...

What is the current status of trial NCT00345930?

This trial is currently recruiting. The enrollment target is 4,000 participants. The study started on 2004-09. Estimated completion is 2028-07-31.

What conditions does trial NCT00345930 study?

This clinical trial studies the following conditions: Liver Diseases.

Who is sponsoring clinical trial NCT00345930?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00345930 being conducted?

This trial has 6 study locations across California, Indiana, Maryland, Michigan, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Liver Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Liver Diseases

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.